Previous Article | Next Article 
Infection and Immunity, September 1999, p. 4679-4688, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Isolation of Peptides That Mimic Epitopes on a Malarial
Antigen from Random Peptide Libraries Displayed on Phage
Christopher G.
Adda,1
Leann
Tilley,1,2
Robin F.
Anders,3 and
Michael
Foley1,2,*
Department of
Biochemistry1 and the Cooperative
Research Centre for Diagnostic Technologies,2 La
Trobe University, Bundoora, and the Walter and Eliza Hall
Institute of Medical Research, Melbourne,3
Victoria, Australia
Received 28 December 1998/Returned for modification 18 February
1999/Accepted 16 June 1999
 |
ABSTRACT |
The ring-infected erythrocyte surface antigen (RESA) is a
dense-granule protein of Plasmodium falciparum which binds
to the cytoskeletal structure of the erythrocyte after parasite
invasion. It is currently under trial as a vaccine candidate. In an
effort to characterize further the antibody responses to this antigen, we have panned two independent libraries of random peptides expressed on the surface of filamentous phage with a monoclonal antibody (MAb
18/2) against RESA. One library consisted of a potentially constrained
17-mer peptide fused with the gpVIII phage coat protein, and the other
displayed an unconstrained 15-mer as a fusion with the minor phage coat
protein gpIII. Several rounds of biopanning resulted in enrichment from
both libraries clones that interacted specifically with MAb 18/2 in
protein-blotting and enzyme-linked immunosorbent assay experiments.
Nucleotide sequencing of the random oligonucleotide insert revealed a
common predominant motif: (S/T)AVDD. Several other clones had related
but degenerate motifs. Thus, a monoclonal antibody against a malarial
antigen can select common mimotopes from different random peptide
libraries. We envisage many uses for this technology in malaria research.
 |
INTRODUCTION |
Libraries of random peptides
expressed on the surface of phage provide vast pools of diverse
molecular structures from which peptides with binding affinities toward
desired molecules can be selected (39). Screening such
libraries has emerged as a powerful tool in the identification of small
peptides that mimic structural and functional features of larger
molecules, e.g., identification of epitopes or mimotopes (a peptide
that mimics an epitope but has a different primary amino acid sequence)
on antigens (28). In addition, small peptides with affinity
for molecules involved in biological interactions (such as receptors) can be isolated and assessed as possible functional modulators. We have
used phage peptide technology to obtain mimotopes for an important
malarial antigen, the ring-infected erythrocyte surface antigen (RESA).
RESA is a protein produced by the most pathogenic of the human malaria
parasites, Plasmodium falciparum. Although some
culture-adapted parasite isolates do not express RESA, it is found in
all field isolates of P. falciparum, suggesting that it
facilitates survival of the parasite in vivo (31). RESA is
produced in the final stages of schizont development and stored in
dense granules within the developing merozoite (3).
Following rupture and merozoite reinvasion, RESA is secreted into the
newly formed parasitophorous vacuole and then transported, by an
unknown mechanism, to the erythrocyte membrane skeleton
(16). RESA interacts with erythrocyte spectrin and
stabilizes the erythrocyte membrane (17, 22).
The spectrin-binding region of the RESA polypeptide has been mapped to
the region between amino acids 670 and 770 (20). RESA also
contains a region that has homology to the conserved J region of the
Escherichia coli molecular chaperone, DnaJ (11). This region may be responsible for the proposed chaperone-like activity
of RESA (17, 21). These functional regions of the RESA
molecule are flanked by two regions of repetitive acidic amino acid
sequence, the so-called 5' and 3' repeat regions. These acidic repeats
represent immunodominant epitopes (19) and are recognized by
sera of people who are naturally exposed to malaria (32).
Indeed, a number of studies examining malaria endemicity and other
seroepidemiological parameters have relied on synthetic peptides
corresponding to the linear repeat sequences of RESA (29, 33,
34). The function of the repetitive sequences of RESA is not
clear. Many malaria antigens have extensive regions of their amino acid
sequence composed of repetitive sequences, some of which are probably
the targets of the protective immune response (6). Other
repeats, including some that are recognized as dominant epitopes by the
host immune system, may function as molecular "smoke screens,"
decreasing the ability of the host to mount an effective immune
response (4, 26).
Although RESA is not exposed at the surface of the infected erythrocyte
(3) and is not essential for growth in vitro
(12), evidence from several studies has indicated that
antibodies against RESA can inhibit the invasion of merozoites into the
host erythrocyte (1, 38). Moreover, immunization of
Aotus monkeys with recombinant RESA offers some protection
from malaria challenge (14). This has led to the idea that
antibodies to the RESA molecule might cross-react with another malarial
protein that plays an important role in invasion or development of the
intraerythrocytic parasite. A diacidic motif found within both the 5'
and 3' repeat regions of RESA is also found within the repeat regions
of the falciparum interspersed repeat antigen, the FC27 S-antigen,
Pf332, Pf11.1, and erythrocyte band 3 (6, 25, 38). A human
monoclonal antibody (MAb 33G2) has been shown to cross-react with Pf322
and RESA (27). Indeed, anti-Pf322 antibodies that
cross-react with the acidic repeat regions at the C terminus of RESA
were found to inhibit the growth of parasites even when the parasite
strain did not express RESA (38). These studies suggest that
antibodies recognizing the repeat regions of RESA may be important
antimalarial agents due to their promiscuous binding activity and to
the presence of diacidic motifs in many parasite antigens.
In this study, we used phage peptide technology to obtain information
about the binding specificity of an anti-RESA monoclonal antibody, MAb
18/2. MAb 18/2 was raised against a C-terminal recombinant fragment of
RESA (residues 893 to 1073) containing the 3' repeat sequences
(5). It also cross-reacts with 5' repeat sequences of RESA
which are also rich in acidic amino acids (5). MAb 18/2 has
been used extensively as a research tool to reveal much about the role
of RESA in the newly infected erythrocyte (17, 22). It was
used to pan two independent random peptide libraries displayed on the
surface of filamentous phage. Peptides that bind to the antigen-binding
site of MAb 18/2 might be expected to mimic the structure of the acidic
repeat regions of RESA. It was anticipated that these peptides would
provide information about the fine structure of epitopes on RESA and
might prove useful in understanding the nature of the epitopes of
cross-reactive antigens that may help parasites evade the protective
immune response.
 |
MATERIALS AND METHODS |
Parasites.
The P. falciparum cloned line FAC-8
was continuously cultured as described by Trager and Jensen
(37).
Phage library preparation.
The 15-mer phage peptide library
was kindly provided by George Smith, University of Missouri, Columbia,
Mo. (35), and the 17-mer library was provided by Jamie
Scott, Simon Fraser University, British Columbia, Canada
(10). Phage were amplified, based on a procedure by Smith
and Scott (36), by infecting a log-phase culture of E. coli K91 and shaking overnight at 37°C in Luria-Bertani medium
containing 2% tetracycline. The supernatant was twice clarified by
pelleting the cells at 10,000 × g for 15 min, and 0.2 volume of PEG solution (20% polyethylene glycol 8000, 2.5 M NaCl) was added. The sample was incubated at 4°C for at least 2 h before being centrifuged at 16,000 × g for 50 min to
precipitate the phage. The phage pellet was resuspended in 1 ml of TBS
(50 mM Tris, 150 mM NaCl [pH 7.5]) and stored at 4°C with 0.02%
NaN3.
Panning the phage libraries.
An adaptation of the technique
used by Parmley and Smith (30) was used to screen the phage
peptide libraries on MAb 18/2. The wells of a 96-well enzyme-linked
immunosorbent assay (ELISA) plate (Maxisorp; Nunc International) were
coated with MAb 18/2 (0.5 µg) in 100 µl of binding buffer (0.1 M
NaHCO3) overnight at 4°C in a humidified container. The
wells were blocked for 2 h at 4°C with 400 µl of blocking
solution (0.5% bovine serum albumin [BSA], 0.1 M NaHCO3
[pH 8.6]). Phage (approximately 1011 particles) in 100 µl of probing solution (0.5% BSA in TBS) were added to the wells and
left for 50 min at room temperature. After incubation, the wells were
washed vigorously twice in the first round and four times in subsequent
rounds of panning with TBS-T (0.5% Tween 20 in TBS) to remove
nonbinding phage. Phage bound to the antibody were eluted with 100 µl
of elution solution (0.1 M glycine [pH 2.2]) for 15 min at room
temperature and neutralized with 7 µl of 2 M Tris. The titer of
eluted phage was estimated, and an aliquot of the eluted fraction was
used to infect E. coli K91 cells for amplification.
Phage titer determinations.
Phage were subjected to titer
determination by the procedure described by Scott and Smith
(35). Phage were subjected to serial 10-fold dilutions with
100 µl of water in a 96-well microtiter plate (Maxisorp; Nunc
International). To each of the phage dilutions, 100 µl of log-phase
E. coli K91 cells was added, and the mixture was incubated
at room temperature for 20 min to allow the phage to infect the
E. coli cells. A 20-µl aliquot of each dilution was spread
onto agar plates containing 4% tetracycline and incubated overnight at
37°C. Phage infection of bacteria confers resistance to tetracycline,
and such colonies were counted and expressed as CFU per milliliter.
Western blotting.
A total of 1010 phage
particles from selected clones were boiled for 3 min in the presence of
sodium dodecyl sulfate (SDS) sample buffer (10% glycerol, 63 mM Tris
[pH 6.8], 2% SDS, 0.0025% bromophenol blue) with or without 10%
-mercaptoethanol and applied to 10 to 20% Tricine gels (Novex, San
Diego, Calif.). Separated proteins were then transferred to a
polyvinylidene difluoride transfer membrane (PVDF-Plus; Millipore,
Bedford, Mass.), and the membrane was blocked overnight in 5% Blotto
(5% skim milk powder) and probed with MAb 18/2. Horseradish peroxidase
(HRP)-conjugated anti-mouse immunoglobulin G (IgG) was used as a
secondary antibody, and binding was detected by enhanced
chemiluminescence (ECL) (Pierce Chemical Co. Rockford, Ill.).
ELISAs.
Phage enzyme-linked immunosorbent assays (ELISAs)
were performed, using a procedure similar to that described by Harlow
and Lane (24), by coating 96-well plates (Nunc) with MAb
18/2, polyclonal rabbit antisera raised against rat chaperone 60, anti-cpn60 (a kind gift from N. Hoogenraad, Department of Biochemistry,
La Trobe University, Bundoora, Australia), or 4D6, a mouse monoclonal
antibody reactive with apical membrane antigen (AMA-1) from
Plasmodium chabaudi (5 µg/ml) (6a). Phage,
diluted in probing solution (0.5% BSA in TBS), were added to the wells
and incubated for 40 min at room temperature. The wells were washed
five times with TBS-T, and bound phage were detected with an
anti-M13-HRP antibody (Pharmacia Biotech, Quarry Bay, Hong Kong) by
using o-phenylenediamine as an enzyme substrate. For
competition experiments, 1010 phage particles were added to
the MAb 18/2-coated wells (0.5 µg/well) in the presence of increasing
amounts of recombinant RESA (RESA-322 [17]) or
synthetic peptide. In ELISAs involving the detection of synthetic
peptides, 96-well plates were coated with 1 µg of synthetic peptide.
MAb 18/2, diluted in probing solution, was added to the wells as the
primary antibody and detected with an anti-mouse IgG-HRP antibody
(Amersham Australia Pty Ltd.) as described above. For competition
experiments, increasing amounts of synthetic peptide were added along
with the primary antibody. ELISAs involving pooled human sera from
Papua New Guinea were performed in essentially that same manner as
described above. An anti-human IgG-HRP antibody (Amersham Australia Pty
Ltd.) was used to detect the human sera.
Nucleotide sequencing.
PCR was used to amplify the region of
the phage genome encoding the peptide sequence with phage DNA released
from E. coli K91 cells by boiling. The relevant primers were
as follows: 15-mer library (gpIII), 5' primer (GAT AAA CCG ATA CAA TTA
AAG) and 3' primer (CAC AGA CAA CCC TCA TAG); 17-mer library (gpVIII),
5' primer (CTG AAG AGA GTC AAA AGC) and 3' primer (CAA TTT CTT AAT GGA
AAC). The amplified fragments were sequenced at least twice by
automated dye terminator cycle sequencing (Amersham Australia Pty
Ltd.). Sequences were analyzed with DNASIS V2.1 (Hitachi Software Engineering Co., Ltd.) computer software.
Peptide synthesis.
Peptides 15(1) (CFDYAPYVSAVDDIC), 17(3)
(GLKNCTVQPWDATDVCD), 17(3j) (GAQLDCTVKTPDVWDCN), and 8-mer
[(EENVEHDA)4] were synthesized by Auspep Pty
Ltd. Peptides RESA 0 (SNDQKYSIEDSLTIK), 11-mer
[(DDEHVEEPTVA)2], BSA-11-mer
[(DDEHVEEPTVA)3], and 4-mer [(EENV)8] were
synthesized by the Joint Protein Structure Laboratory (Walter and Eliza
Hall Institute of Medical Research and the Ludwig Institute for Cancer Research, Melbourne, Australia).
Reduction and alkylation of peptides.
Peptides 17(3), 15(1),
and 17(3j) (20 µl; 1 mg/ml) were each combined with an equal volume
of 40 mM dithiothreitol and incubated at 70°C for 5 min to reduce
disulfide bonds. A 10-µl volume of 0.2 M iodoacetamide was then
added, and the mixture was incubated for 60 min to alkylate each
reduced peptide. The peptides were subsequently immobilized on the
wells of an ELISA plate (1 µg/well) and probed with MAb 18/2 as
described previously.
Indirect-immunofluorescence assay.
Indirect-immunofluorescence assays were carried out essentially
as described previously (9) with MAb 18/2 as a primary antibody and a fluorescein isothiocyanate-labelled anti-mouse secondary
antibody (Sigma Chemical Co., St. Louis, Mo.).
Peptide inhibition of antibody binding to parasite-produced
RESA.
P. falciparum FAC-8 was grown to approximately
10% ring stage parasitemia. The erythrocytes were isolated by
centrifugation and incubated with 2 volumes of 0.2% saponin (Sigma
Chemical Co.) at 37°C for 20 min to release the hemoglobin. The lysed
cells were washed in phosphate-buffered saline (137 mM NaCl, 2.7 mM KCl, 10.1 mM Na2HPO4, 1.8 mM
KH2PO4 [pH 8]) until all the hemoglobin was
removed from the cells. A 25-µl volume of packed cells, diluted in
150 µl of probing solution, was incubated with 0.1 µg of MAb 18/2
in the presence or absence of peptide for 40 min at room temperature.
The cells were washed four times with TBS, and the amount of bound MAb
18/2 was assessed by using an alkaline phosphatase-coupled anti-mouse
IgG (Sigma Chemical Co.) followed by adding 200 µl of
p-nitrophenyl phosphate alkaline phosphatase substrate as
specified by the manufacturer (Sigma Chemical Co.). The cells were
pelleted, and the supernatant was analyzed spectrophotometrically at
405 nm.
 |
RESULTS |
Panning and ELISA screening.
To identify peptides that can
mimic structural features of the malarial protein RESA, we used the
anti-RESA MAb 18/2 to pan two independent phage-displayed random
peptide libraries. One of the libraries contains phage expressing
random 15-residue peptides fused to the minor coat protein gpIII and
present at 5 copies per phage particle (35), and the other
library contains phage expressing approximately 250 copies of a
17-residue peptide library (X15CX), with an invariant
penultimate cysteine residue, as a fusion to the gpVIII coat protein
(10). The latter library has a diversity of 1.2 × 108 clones. Four rounds of panning resulted in an
approximately 1,000-fold enrichment of eluted phage (Fig.
1A). Phage pools after two rounds of
panning exhibited enhanced binding to MAb 18/2, whereas no binding to
BSA or the irrelevant antibody MAb 4D6 was seen with pooled phage from
any of the four rounds of panning, indicating enrichment of phage with
specific binding characteristics during the panning procedure (Fig.
1B).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 1.
Enrichment of phage during panning. (A) Titers of phage
applied to (bars A) and eluted from (bars E) plastic wells at each
round of panning. The phage collected after three rounds of panning
(3E) were used to pan on a control protein, BSA. (B) Phage ELISA of
pools of clones after each round of panning. Pooled phage were
amplified, and 1010 phage were added to each well of a
microtiter plate precoated with MAb 18/2, anti-AMA-1 (4D6), or BSA.
Phage were detected with an anti-M13-HRP antibody. OD 450nm, optical
density at 450 nm.
|
|
Amino acid sequences of peptide inserts in phage that bind to MAb
18/2.
Although the precise epitope of MAb 18/2 has not been
determined, the antibody recognizes both the 5' and 3' repeat regions of the RESA antigen. After two or four rounds of panning, individual phage clones were propagated and the region of DNA corresponding to the
random peptide was sequenced. Peptides isolated from the 15-mer library
after two rounds of panning were fairly diverse. After four rounds of
panning, this diversity decreased. After four rounds of panning, most
of the isolated sequences contained a common SAVDD motif within
different amino acid sequence contexts (Fig.
2A). There was some degeneracy in the
motif, with one peptide [15(5)] having SVEE and another [15(6)]
having only the diacidic (DD) residues in common. Although there was no
exact identity between the peptides isolated and RESA sequences
(19), the majority of the peptides contained a diacidic
sequence immediately preceded by a hydrophobic residue, which is a
motif found in both the 5' and 3' RESA repeats. Acidic residues were
significantly enriched in the selected peptides (Fig. 2). This is
significant, since Couet et al. have estimated that the expected
occurrence of acidic residues in the 15-mer library is only 5%
(15). In contrast, the proportion of acidic residues in the
isolated peptides was 14%, almost threefold higher than expected,
perhaps reflecting the acidic nature of the epitope on RESA recognized
by MAb 18/2. One peptide isolated from the 15-mer library, 15(7), did
not appear to have any homology to the consensus motif (Fig. 2A).

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 2.
Deduced amino acid sequences of individual clones
obtained after two to four rounds of panning of the phage libraries on
MAb 18/2. (A) Sequences of inserts from phage isolated from the 15-mer
library. (B) Sequences of inserts from phage isolated from the 17-mer
library. Regions of similarity within the peptides are boxed. (C)
Alignment of selected clones from the two libraries revealing a
secondary motif (boxed) within the amino acid sequences. The AAEEGDD
sequence in the last two clones is derived from the gene III protein
immediately following the insert.
|
|
The peptides isolated from the 17-mer library were more diverse in
sequence but were again rich in acidic amino acids. The presence of a
common motif was less obvious; however, the preference for serine,
threonine, valine, and aspartic acid suggests a loose motif with
structural similarity to SAVDD. Interestingly, one of the peptides
[17(1)] contained the motif TAVDD (Fig. 2B), which is clearly related
to the SAVDD motif identified from the 15-mer library. Hence, we
propose the consensus motif (S/T)AVDD. Further comparison of the clones
from the two different libraries identified peptides 15(8) and 17(7) as
sharing a different motif, SAVPXXD, where X is any amino acid (Fig.
2C). These two peptides, when grouped with other selected peptides,
allowed the assignment of a second consensus sequence, SAXXXXD, which
was present in five peptides within different amino acid contexts. The
binding of a representative peptide, 15(6) (GSFSAEHFLDDFAIW), to MAb
18/2 has been confirmed (Fig. 3 and
4B). Interestingly, sequences of two of
these five peptides [peptides 17(8) and 17(4) (Fig. 2C)] align with
this second consensus motif only if the phage protein backbone of
gpVIII to which the peptides are fused is considered to contribute to
the binding. This may explain the surprising observation that a phage
displaying a peptide insert of only two residues [alanine and serine;
peptide 17(8)] was selected from the library. We also isolated
peptides from these libraries [i.e., peptides 15(7), 17(5), and
17(6)] that did not conform to any of these consensus patterns.


View larger version (63K):
[in this window]
[in a new window]
|
FIG. 3.
Interaction of isolated phage clones with MAb 18/2. (A)
Analysis by Western blotting. Selected phage clones from each of the
two libraries and wild-type M13 phage as a control were separated by
SDS-polyacrylamide gel electrophoresis (10% polyacrylamide),
transferred to PVDF membranes, and probed with MAb 18/2. The positions
of peptides 15(5), 15(1), 15(4), 15(6), 15(7), 15(3), and 15(2) fused
to gpIII and peptides 17(1) and 17(3) fused to gpVIII were visualized
by ECL. No binding was observed to gpIII on wild-type M13 phage (H).
(B) Effect of reduction and alkylation on binding of mimotopes to MAb
18/2. Peptides 15(1), 17(3), and 17(3j), either cyclized or reduced and
alkylated (R+A), were immobilized on the wells of an ELISA plate and
probed with MAb 18/2. Binding was detected by HRP-conjugated anti-mouse
antibody. OD 450nm, optical density at 450 nm.
|
|

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 4.
Analysis of specificity and affinity of binding of
phage-displayed peptides to MAb 18/2. Increasing numbers of phage of
representative clones from the 17-mer library (A), the 15-mer library
(B), and wild-type M13 phage were applied to wells of an ELISA plate
coated with MAb 18/2. The binding of peptides 15(3) and 17(3) to two
other antibodies, anti-chaperone 60 and anti-AMA-1 (4D6), were also
examined. This data is representative of an experiment that was
performed on three separate occasions. OD 450nm, optical density at 450 nm.
|
|
Binding specificity of selected phage to MAb 18/2.
When the
proteins of the selected phage were separated under nonreducing
conditions by SDS-polyacrylamide gel electrophoresis and blotted onto
polyvinylidene difluoride (PVDF) membranes, MAb 18/2 recognized the
peptide fused gene product; however, there was no binding of MAb 18/2
to wild-type M13 proteins which did not display any foreign peptides
(Fig. 3A).
A number of the isolated peptides from both libraries contained two
cysteine residues. This was particularly noted for peptides isolated
from the 17-mer library, where there was an invariant cysteine
engineered into the sequence. This suggested that an intramolecular
disulfide bond might contribute to the conformation of some of the
peptide structures. To further investigate this possibility, phage
clones from the cysteine-containing 15-mer library were separated under
reducing conditions. These reduced polypeptides were still recognized
by MAb 18/2 on a Western blot (Fig. 3A), suggesting that a disulfide
bond between the two cysteine residues present in some peptides is not
essential for the interaction with the monoclonal antibody
antigen-binding site. MAb 18/2 was also able to bind to both peptides
15(1) and 17(3) when produced as cyclized peptides; however, we have
shown that when these peptides are reduced and alkylated, the binding
of 15(1) to MAb 18/2 is unaffected whereas the binding of 17(3) is
significantly reduced. Nevertheless, there is still substantial binding
of 17(3) to MAb 18/2 (Fig. 3B). Mass spectrometry has confirmed that
more than 95% of the peptides were correctly reduced and alkylated
(data not shown).
Phage isolated from both libraries also bound to MAb 18/2-coated ELISA
plates (Fig. 4). In contrast, phage lacking a peptide (wild-type M13
phage) did not bind to MAb 18/2, and one phage clone [17(6)] with the
insert sequence YVGSQSEDRDMSCGHCS, which lacks the consensus motif, also did not bind (Fig. 4A). Phage from both
libraries, which showed high-affinity binding to MAb 18/2, did not bind
to an irrelevant monoclonal antibody, MAb 4D6, or to antisera to the
irrelevant protein, Cpn60 (Fig. 4). Taken together, these data indicate
that the majority of the isolated peptide sequences bind specifically
to the antigen-binding site of MAb 18/2 and display a range of apparent
binding affinities and hence mimic epitopes on RESA.
RESA protein inhibits binding of MAb 18/2 to selected phage.
If the peptide sequences mimic epitopes on RESA, RESA would be expected
to compete with phage displaying these sequences for binding to MAb
18/2. Figure 5 demonstrates that a
recombinant bacterially expressed form of RESA (amino acids 322 to
1073), which includes both repeat regions, reduces the binding of
selected phage clones to immobilized MAb 18/2 in a dose-dependent
manner.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 5.
Inhibition by RESA of the binding of phage clones to MAb
18/2. MAb 18/2 was immobilized on the wells of an ELISA plate, and a
constant amount of phage from the 15-mer library (A) or the 17-mer
library (B) was added to each well in the presence of increasing
amounts of RESA-322. Binding of phage was assessed with an
anti-M13-HRP antibody. OD 450nm, optical density at 450 nm.
|
|
Synthetic peptides are RESA mimotopes.
To confirm that the
peptide sequences are true mimics of structural features of RESA, a
representative peptide from each library was synthesized [17(3)
(GLKNCTVQPWDATDVCD) and 15(1) (CFDYAPYVSAVDDIC)] and
their binding specificities for MAb 18/2 were determined. Both peptides
inhibited the binding to MAb 18/2 of phage displaying the corresponding
peptide (Fig. 6A and B). This
demonstrates that the phage scaffold is not necessary for the binding
of the mimotopes to MAb 18/2. A peptide with the same amino acid
composition as peptide 17(3) but with a randomized sequence [peptide
17(3j) (GAQLDCTVKTPDVWDCN)] had no
effect on binding (Fig. 6A and B). Thus the primary sequence, and not
simply the acidic nature of the peptide, appears to be critical for
efficient binding to the antigen-binding site of MAb 18/2.
Interestingly, the two synthetic peptides were capable of inhibiting
the binding of most of the other phage-displayed mimotopes to MAb 18/2
despite the marked differences in amino acid sequences (Fig. 6C). It
would appear, therefore, that despite the wide divergence of mimotope
sequences identified in this study, they all have a similar fine
specificity (i.e., they bind to spatially overlapping sites within the
antigen-binding site).

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 6.
Inhibition by synthetic peptides of the interaction of
phage clones with MAb 18/2. (A and B) MAb 18/2 was immobilized on the
wells of an ELISA plate and probed with a constant amount
(1010 phage) of phage clone 17(3) in the presence of
increasing amounts of synthetic 17(3) peptide or the control peptide
17(3j) (A) or phage clone 15(1) in the presence of increasing amounts
of synthetic 15(1) peptide or the control peptide 17(3j) (B). (C) MAb
18/2 was immobilized on the wells of an ELISA plate and probed with a
constant amount (1010 phage) of 11 different phage clones
in the presence of no peptide, 5 µg of a synthetic version of peptide
17(3), 5 µg of peptide 15(1), or 5 µg of the control peptide
17(3j). OD 450nm, optical density at 450 nm.
|
|
MAb 18/2 specifically recognizes RESA associated with the membrane
skeleton of erythrocytes infected with ring stage parasites. We
performed immunofluorescence experiments with MAb 18/2 on parasites growing in vitro (Fig. 7). The two
synthetic peptides, 17(3) (GLKNCTVQPWDATDVCD) and 15(1)
(CFDYAPYVSAVDDIC), inhibited the binding of MAb 18/2 to RESA as shown
by a decrease in the signal in the immunofluorescence assay (Fig. 7).
An irrelevant peptide, SNDQKYSIEDSLTIK (RESA 0), consisting of a
randomized stretch of amino acids from RESA was unable to inhibit
fluorescence (Fig. 7). Confirmation that both 15(1) and 17(3) peptides
can block the binding of MAb 18/2 to RESA in situ was obtained by
measuring the amount of antibody bound in the presence of mimotope in a
modified ELISA format (see Materials and Methods). Both peptides
blocked binding of the antibody to RESA, whereas an irrelevant peptide
had little effect (Fig. 7C). Thus, binding of MAb 18/2 to authentic
RESA (i.e., as it is presented by intraerythrocytic parasites) is
inhibited by these phage-derived mimotopes. This emphasizes the
structural similarity between these peptides and immunodominant regions
of RESA. To explore the relationship between the mimotopes isolated in
this study and the RESA repeat regions, we first examined the binding of MAb 18/2 to peptides representing the major repeats of RESA. MAb
18/2 recognized all three peptides, i.e., 4-mer, BSA-conjugated 8-mer,
and BSA-conjugated 11-mer, as well as 17(3) and 15(1) mimotopes (see
Materials and Methods for peptide sequences), although the 8-mer
peptide appeared less reactive than the others (Fig.
8A). This confirms that MAb 18/2 reacts
with sequences in both the 5' and 3' repeats of RESA. Interestingly,
all three peptides representing the RESA repeats were able to block the
binding of MAb 18/2 to both 17(3) and 15(1) mimotopes (Fig. 8B). These
results strengthen the proposal that mimotopes selected on MAb 18/2
accurately represent authentic antigenic sites on RESA. To obtain
support for the assertion that these mimotopes are relevant to the
natural immune response induced by RESA, we examined the ability of
sera from Papua New Guinea to recognize the phage clones. In ELISAs,
pooled sera from malaria-infected individuals from a region of Papua
New Guinea where malaria is endemic (8) showed a
fourfold-higher response to peptide 17(3) and a threefold higher
response to peptide 15(1) than the background signal observed with
pooled sera from a group of non-infected control individuals in
Melbourne (Fig. 8C).

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 7.
Inhibition of MAb 18/2 binding to parasite-expressed
RESA by mimotopes. (A and B) Immunofluorescence experiments were
carried out with MAb 18/2 to visualize RESA on infected erythrocyte
membranes (A). This fluorescence was greatly reduced by the presence of
1 µg of 15-mer peptide (B). (C) Infected cultures were washed and
incubated with MAb 18/2 in the absence of peptide (shaded bar) in the
presence of various concentrations of 15(1) peptide or 17(3) peptide,
or in the presence of 20 µg of a control peptide RESA 0. After
addition of an alkaline phosphatase-coupled anti-mouse IgG, MAb 18/2
binding was determined by assaying the supernatants
spectrophotometrically at 405 nm (OD 405nm).
|
|


View larger version (55K):
[in this window]
[in a new window]
|
FIG. 8.
Binding of MAb 18/2 to mimotopes and synthetic peptides
corresponding to the RESA repeats. (A) BSA-conjugated peptides 11-mer
(DDEHVEEPTVA)3 and 8-mer (EENVEHDA)4 (see
Materials and Methods for details), 4-mer, 15(1), 17(3), and RESA 0 were immobilized on the wells of an ELISA plate and probed with MAb
18/2. Bound antibody was detected with an HRP-coupled anti-mouse IgG.
(B) Inhibition by synthetic peptides of the interaction of peptides
17(3) and 15(1) with MAb 18/2. Immobilized peptides 17(3) and 15(1)
were probed with MAb 18/2 in the presence of 10 µg of the 4-mer,
8-mer, and 11-mer peptides. Bound antibody was detected with an
HRP-coupled anti-mouse IgG. (C) Binding of pooled human sera to RESA
and two synthetic mimotopes, 17(3) and 15(1). Recombinant RESA-322 and
peptides were immobilized on the wells of an ELISA plate and probed
with pooled human sera from individuals from Papua New Guinea (PNG) and
Melbourne. Bound antibody was detected with HRP-coupled anti-human IgG.
OD 450nm, optical density at 450 nm.
|
|
 |
DISCUSSION |
In this study, we have examined the utility of random peptide
libraries displayed on the surface of bacteriophage as repositories of
molecular structures, some of which will mimic structural and perhaps
functional regions of important malaria antigens. We chose to pan two
random peptide libraries with MAb 18/2, which recognizes epitopes
within the acidic repeats of the malarial antigen RESA. MAb 18/2 was
raised against a C-terminal fragment of RESA fragment. This region of
RESA contains the 3' repeats, which consist of 29 copies of a
4-amino-acid sequence (EENV) plus 5 copies of an extended
(8-amino-acid) version of this repeat (EENVEHDA). The exact epitope
recognized by MAb 18/2 has not been mapped; however, it is likely to
include the hydrophobic, diacidic motif which is present in the 5' and
3' repeats of RESA (19) recognized by MAb 18/2.
Panning of two independent random peptide libraries with MAb 18/2
identified a set of peptides that bound to the antigen-binding site of
this antibody. Although the selected peptides had no extensive identity
to sequences within RESA, they had characteristics that might be
expected of RESA mimotopes. It is not clear why there was no selection
of peptides that closely resembled the 4-mer sequence, EENV, or the
8-mer sequence, EENVEHDA. It is possible that these sequences are not
represented in the two libraries used in this study or, alternatively,
are not tolerated by the phage or the bacteria in which the phage are
propagated due to adverse effects or production of unfavorable
conformations of the phage fusion protein and hence would not be
accessible for selection during the panning procedure. Isolation of
mimotopes
peptides that are not identical to the original epitope but
are still able to bind to the antigen-binding site of an antibody due
to sufficient structural similarities
from random peptide libraries
has been reported by others (18, 23). Indeed, it appears to
be uncommon to isolate an exact match for an epitope from a random
peptide library. In this study, the overall negative charge of the
isolated peptides was high, suggesting that the peptides mimic the high glutamate and aspartic acid content of RESA repeats. The consensus motif identified from the 15-mer library, SAVDD, had a closely related
counterpart, TAVDD, in the set of peptides enriched from the 17-mer
library. The consensus motif (S/T)AVDD most closely resembles the
sequences TVADD, TVADE, and TVAEE, which are found within the 5' repeat
region of RESA, perhaps suggesting that MAb 18/2 may have a higher
affinity for epitopes within the 11-mer repeats. This result is
slightly surprising, since although MAb 18/2 reacts with both 3' and 5'
repeats, the antibody was raised against a recombinant protein
containing the 4-mer and 8-mer repeats only. A deeper understanding of
this interaction was obtained by competition experiments between the
mimotopes and synthetic peptides representing the three dominant repeat
motifs in RESA, 4-mer (EENV)8, 8-mer
(EENVEHDA)4, and 11-mer (DDEHVEEPTVA).
We have shown that MAb 18/2 recognized all three synthetic peptides
from the 5' and 3' repeats of RESA and that all three RESA peptides
were able to inhibit the binding of MAb 18/2 to the mimotopes (Fig. 8A
and B), demonstrating the shared properties of the mimotopes and the
RESA-derived sequences. It was interesting that the synthetic 8-mer
gave the lowest binding to MAb 18/2, whereas it was the 11-mer that was
the least effective at blocking the interaction between MAb 18/2 and
the mimotopes, perhaps reflecting the local conformational differences
between peptides attached to a solid substrate and those same peptides
in solution.
Pf332, a megadalton protein consisting primarily of 11-amino-acid
repeat sequences (2, 27), contains three sequences (SVTEE,
SVTDE, and SVTED) that resemble the consensus (S/T)AVDD motif
identified in this study. The human monoclonal antibody (MAb 33G2) is
an efficient inhibitor of parasite invasion in vitro (38)
and has been shown to recognize both RESA and Pf332. Although it is not
known whether MAb 18/2 or the antisera generated against the mimotopes
identified here are inhibitory, one study has revealed a correlation
between antibodies against the RESA 4-mer repeated epitope and
protection against malaria infection (7) while another study
has demonstrated that antibodies to RESA repeats inhibit malaria
invasion (13). Ahlborg et al. have also shown that
antibodies reactive with RESA repeats inhibit the growth of malaria
parasites (1). Interpretation of these results is unclear
because of the network of cross-reactions that exist between P. falciparum antigens containing hydrophobic-diacidic motifs. Peptides isolated by panning phage display libraries may help define
more clearly the functional cross-reactivities between antibodies to
different malarial antigens.
Two of the peptide inserts selected from the 17-mer library by panning
on MAb 18/2 contained large deletions. One insert consisted of only 2 amino acids, and the other contained 6 residues instead of the expected
17. Deviant sequences have previously been observed in this 17-mer
library (10); however, it was surprising that a clone
containing a peptide insert of only 2 amino acids bound to MAb 18/2
while phage containing no insert exhibited no binding activity.
Presumably, the adjacent sequence of the phage protein gpVIII combines
with the AS insert to constitute a mimotope of MAb 18/2. The
involvement of the phage environment in binding of phage-displayed
peptides to an antibody is a phenomenon that has been proposed
previously (18). Interestingly, both deleted peptides end in
a serine residue, which, when considered along with the next 6 adjacent
gpVIII residues (AAEGDD), conforms to a second consensus motif,
SAXXXXD, found in MAb 18/2-binding clones isolated from both libraries
(Fig. 2C).
Of the two libraries we used, the first consists of 15 completely
random amino acids expressed at the N terminus of the phage protein
gpIII and the second has 15 random amino acids followed by a fixed
cysteine residue, which is immediately followed by another random amino
acid. This latter library can be considered to be
"semiconstrained," since single cysteine residues are not favored
and panning tends to select for a second cysteine elsewhere within the
peptide (10, 40). We did observe a number of second cysteine
residues within the peptides isolated from the 17-mer library (Fig.
2B). It was also noted that two peptides containing two cysteine
residues were isolated from the 15-mer library, although this library
had no particular selection pressure in favor of disulfide bonds.
Although disulfide bound formation between the two cysteine residues
probably does occur for at least some of the isolated peptide inserts
(40), the disulfide bridges in the selected peptides do not
appear to be essential for the binding to MAb 18/2 since they were
still able to bind to MAb 18/2 after elimination of the disulfide bond
by reduction and alkylation. The disulfide bond in mimotope 17(3) does
appear to play a role in maintaining the integrity of the peptide so
that it can bind efficiently to MAb 18/2, since reduction and
alkylation leads to a decrease in MAb 18/2 binding (Fig. 3B). Disulfide
bond formation may play a role in stabilization of the peptides during
their route through the bacterial periplasm or possibly in allowing the
peptide to be efficiently packaged on the phage surface and extruded as
completed phage particles.
Our results demonstrate that small peptides can mimic features of
repeat regions of large P. falciparum proteins. The peptide mimotopes inhibit the binding of MAb 18/2 to a recombinant fragment of
RESA and also to authentic RESA within the malaria parasite. Such
peptide mimotopes and those corresponding to other malarial antigens
may prove useful markers for monitoring the seroepidemiology in
communities where malaria is endemic. Numerous studies examining malaria endemicity and other seroepidemiological parameters have relied
on synthetic peptides corresponding to the linear repeat sequences of
RESA (29, 33, 34). It seems likely that mimotopes isolated
with anti-RESA antibodies would more closely mimic the presentation of
RESA within the parasite, since any effects of conformation within the
repeat regions may not be faithfully represented in short synthetic
peptides based solely on primary sequence of the antigen. The
observation that sera from individuals from a malaria-endemic area
recognize synthetic mimotopes (Fig. 8C) supports this proposal.
Furthermore small peptides have obvious advantages over parasite
extracts or recombinant antigens in terms of stability and
cost-effectiveness, and it may be possible to identify a small set of
peptides that could represent many variants of a particular highly
variable antigen.
We believe that random peptide libraries displayed on phage can be used
to aid in the search for peptides with improved diagnostic and
therapeutic potential as well as peptides for probing the molecular
interactions between the malaria parasite and its host.
 |
ACKNOWLEDGMENTS |
This work was supported by the Australian Research Council and
the National Health and Medical Research Council of Australia and La
Trobe University Grants Scheme.
We thank Sue Mullins for excellent technical support.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemistry, La Trobe University, Bundoora, Victoria 3083, Australia. Phone: 61-3-94792158. Fax: 61-3-9472467. E-mail:
m.foley{at}latrobe.edu.au.
Editor:
J. M. Mansfield
 |
REFERENCES |
| 1.
|
Ahlborg, N.,
J. Iqbal,
L. Bjork,
S. Stahl,
P. Perlmann, and K. Berzins.
1996.
Plasmodium falciparum: differential parasite growth inhibition mediated by antibodies to the antigens Pf332 and Pf155/RESA.
Exp. Parasitol.
82:155-163[Medline].
|
| 2.
|
Ahlborg, N.,
B. Wahlin-Flyg,
J. Iqbal,
P. Perlmann, and K. Berzins.
1993.
Epitope specificity and capacity to inhibit parasite growth in vitro of human antibodies to repeat sequences of the Plasmodium falciparum antigen Ag332.
Parasite Immunol.
15:391-400[Medline].
|
| 3.
|
Aikawa, M.,
M. Torii,
A. Sjolander,
K. Berzins,
P. Perlmann, and L. Miller.
1990.
Pf155/RESA antigen is localized in dense granules of Plasmodium falciparum merozoites.
Exp. Parasitol.
71:326-329[Medline].
|
| 4.
|
al-Yaman, F.,
B. Genton,
J. Reeder,
D. Mokela,
R. Anders, and M. Alpers.
1997.
Humoral response to defined Plasmodium falciparum antigens in cerebral and uncomplicated malaria and their relationship to parasite genotype.
Am. J. Trop. Med. Hyg.
56:430-435.
|
| 5.
|
Anders, R.,
N. Barzaga,
P.-T. Shi,
D. Scanlon,
L. Brown,
L. Thomas,
G. Brown,
H.-D. Stahl,
R. Coppel, and D. Kemp.
1987.
Repetitive sequences in malaria antigens.
UCLA Symp. Mol. Cell. Biol. New Ser.
42:333-342.
|
| 6.
|
Anders, R.,
L. Murray,
L. Thomas,
K. Davern,
G. Brown, and D. Kemp.
1987.
Structure and function of candidate vaccine antigens in Plasmodium falciparum.
Biochem. Soc. Symp.
53:103-114[Medline].
|
| 6a.
| Anders, R. Unpublished data.
|
| 7.
|
Astagneau, P.,
C. Chougnet,
J. Lepers,
M. Andriamangatiana-Rason, and P. Deloron.
1994.
Antibodies to the 4-mer repeat of the ring-infected erythrocyte surface antigen (Pf155/RESA) protect against Plasmodium falciparum malaria.
Int. J. Epidemiol.
23:169-175[Abstract/Free Full Text].
|
| 8.
|
Beck, H.,
I. Felger,
B. Genton,
N. Alexander,
F. al-Yaman,
R. Anders, and M. Alpers.
1995.
Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria.
Infect. Immun.
63:596-600[Abstract].
|
| 9.
|
Bianco, A.,
P. Crewther,
R. Coppel,
H. Stahl,
D. Kemp,
R. Anders, and G. Brown.
1988.
Patterns of antigen expression in asexual blood stages and gametocytes of Plasmodium falciparum.
Am. J. Trop. Med. Hyg.
38:258-267.
|
| 10.
|
Bonnycastle, L.,
J. Mehroke,
M. Rashed,
X. Gong, and J. Scott.
1996.
Probing the basis of antibody reactivity with a panel of constrained peptide libraries displayed by filamentous phage.
J. Mol. Biol.
258:747-762[Medline].
|
| 11.
|
Bork, P.,
C. Sander,
A. Valencia, and B. Bukau.
1992.
A module of the DnaJ heat shock proteins found in malaria parasites.
Trends Biochem. Sci.
17:129[Medline].
|
| 12.
|
Cappai, R.,
M. van Schravendijk,
R. Anders,
M. Peterson,
L. Thomas,
A. Cowman, and D. Kemp.
1989.
Expression of the RESA gene in Plasmodium falciparum isolate FCR3 is prevented by a subtelomeric deletion.
Mol. Cell. Biol.
9:3584-3587[Abstract/Free Full Text].
|
| 13.
|
Carlsson, J.,
R. Udomsangpetch,
B. Wahlin,
N. Ahlborg,
K. Berzins, and P. Perlmann.
1990.
Plasmodium falciparum: differential parasite reactivity of rabbit antibodies to repeated sequences in the antigen Pf155/RESA.
Exp. Parasitol.
71:314-325[Medline].
|
| 14.
|
Collins, W.,
R. Anders,
M. Pappaioanou,
G. Campbell,
G. Brown,
D. Kemp,
R. Coppel,
J. Skinner,
P. Andrysiak,
J. Favaloro,
L. Corcoran,
J. Broderson,
G. Mitchell, and C. Campell.
1986.
Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum.
Nature
323:259-262[Medline].
|
| 15.
|
Couet, J.,
S. Li,
T. Okamoto,
T. Ikezu, and M. Lisanti.
1997.
Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins.
J. Biol. Chem.
272:6525-6533[Abstract/Free Full Text].
|
| 16.
|
Culvenor, J.,
K. Day, and R. Anders.
1991.
Plasmodium falciparum ring-infected erythrocyte surface antigen is released from merozoite dense granules after erythrocyte invasion.
Infect. Immun.
59:1183-1187[Abstract/Free Full Text].
|
| 17.
|
Da Silva, E.,
M. Foley,
A. Dluzewski,
L. Murray,
R. Anders, and L. Tilley.
1994.
The Plasmodium falciparum protein RESA interacts with the erythrocyte cytoskeleton and modifies erythrocyte thermal stability.
Mol. Biochem. Parasitol.
66:59-69[Medline].
|
| 18.
|
Demangel, C.,
P. Lafaye, and J. Mazie.
1996.
Reproducing the immune response against the Plasmodium vivax merozoite surface protein 1 with mimotopes selected from a phage-displayed peptide library.
Mol. Immunol.
33:909-916[Medline].
|
| 19.
|
Favaloro, J.,
R. Coppel,
L. Corcoran,
S. Foote,
G. Brown,
R. Anders, and D. Kemp.
1986.
Structure of the RESA gene of Plasmodium falciparum.
Nucleic Acids Res.
14:8265-8277[Abstract/Free Full Text].
|
| 20.
|
Foley, M.,
L. Corcoran,
L. Tilley, and R. Anders.
1994.
Plasmodium falciparum mapping the membrane-binding domain in the ring-infected erythrocyte surface antigen.
Exp. Parasitol.
79:340-350[Medline].
|
| 21.
|
Foley, M., and L. Tilley.
1995.
Home improvements malaria and the red blood cell.
Parasitol. Today
11:436-439.
|
| 22.
|
Foley, M.,
L. Tilley,
W. Sawyer, and R. Anders.
1991.
The ring-infected erythrocyte surface antigen of Plasmodium falciparum associates with spectrin in the erythrocyte membrane.
Mol. Biochem. Parasitol.
46:137-147[Medline].
|
| 23.
|
Folgori, A.,
R. Tafi,
A. Meola,
F. Felici,
G. Galfre,
R. Cortese,
P. Monaci, and A. Nicosia.
1994.
A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera.
EMBO J.
13:2236-2243[Medline].
|
| 24.
|
Harlow, E., and D. Lane (ed.).
1988.
Antibodies: a laboratory manual.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 25.
|
Holmquist, G.,
R. Udomsangpetch,
K. Berzins,
H. Wigzell, and P. Perlmann.
1988.
Plasmodium chabaudi antigen Pch105, Plasmodium falciparum antigen Pf155, and erythrocyte band 3 share cross-reactive epitopes.
Infect. Immun.
56:1545-1550[Abstract/Free Full Text].
|
| 26.
|
Kemp, D.,
R. Coppel, and R. Anders.
1987.
Repetitive proteins and genes of malaria.
Annu. Rev. Microbiol.
41:181-208[Medline].
|
| 27.
|
Mattei, D.,
K. Berzins,
M. Wahlgren,
R. Udomsangpetch,
P. Perlmann,
H. Griesser,
A. Scherf,
B. Muller-Hill,
S. Bonnefoy,
M. Guillotte,
G. Langsley,
L. Pereira Da Silva, and O. Mercereau-Puijalon.
1989.
Cross-reactive antigenic determinants present on different Plasmodium falciparum blood-stage antigens.
Parasite Immunol.
11:15-30[Medline].
|
| 28.
|
Mennuni, C.,
C. Santini,
D. Lazzaro,
F. Dotta,
L. Farilla,
A. Fierabracci,
G. Bottazzo,
U. Di Mario,
R. Cortese, and A. Luzzago.
1997.
Identification of a novel type 1 diabetes-specific epitope by screening phage libraries with sera from pre-diabetic patients.
J. Mol. Biol.
268:599-606[Medline].
|
| 29.
|
Modiano, D.,
A. Chiucchiuini,
V. Petrarca,
B. Sirima,
G. Luoni,
H. Perlmann,
F. Esposito, and M. Coluzzi.
1998.
Humoral response to Plasmodium falciparum Pf155/ring-infected erythrocyte surface antigen and Pf332 in three sympatric ethnic groups of Burkina Faso.
Am. J. Trop. Med. Hyg.
58:220-224[Abstract].
|
| 30.
|
Parmley, S., and G. Smith.
1988.
Antibody-selectable filamentous fd phage vectors: affinity purification of target genes.
Gene
73:305-318[Medline].
|
| 31.
|
Perlmann, H.,
K. Berzins,
B. Wahlin,
R. Udomsangpetch,
W. Ruangjirachuporn,
M. Wahlgren, and P. Perlmann.
1987.
Absence of antigenic diversity in Pf155, a major parasite antigen in membranes of erythrocytes infected with Plasmodium falciparum.
J. Clin. Microbiol.
25:2347-2354[Abstract/Free Full Text].
|
| 32.
|
Perlmann, H.,
P. Perlmann,
K. Berzins,
B. Wahlin,
M. Troye-Blomberg,
M. Hagstedt,
I. Andersson,
B. Hogh,
E. Petersen, and A. Bjorkman.
1989.
Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components.
Immunol. Rev.
112:115-132[Medline].
|
| 33.
|
Riley, E.,
S. Allen,
M. Troye-Blomberg,
S. Bennett,
H. Perlmann,
G. Andersson,
L. Smedman,
P. Perlmann, and B. Greenwood.
1991.
Association between immune recognition of the malaria vaccine candidate antigen Pf155/RESA and resistance to clinical disease: a prospective study in a malaria-endemic region of west Africa.
Trans. R. Soc. Trop. Med. Hyg.
85:436-443[Medline].
|
| 34.
|
Roy, A.,
V. Sharma, and V. Chauhan.
1994.
The use of peptide ELISA in determining malaria endemicity.
J. Immunol. Methods
167:139-143[Medline].
|
| 35.
|
Scott, J., and G. Smith.
1990.
Searching for peptide ligands with an epitope library.
Science
249:386-390[Abstract/Free Full Text].
|
| 36.
|
Smith, G., and J. Scott.
1993.
Libraries of peptides and proteins displayed on filamentous phage.
Methods Enzymol.
217:228-257[Medline].
|
| 37.
|
Trager, W., and J. Jensen.
1976.
Human malaria parasites in continuous culture.
Science
193:673-675[Abstract/Free Full Text].
|
| 38.
|
Wahlin, B.,
A. Sjolander,
N. Ahlborg,
R. Udomsangpetch,
A. Scherf,
D. Mattei,
K. Berzins, and P. Perlmann.
1992.
Involvement of Pf155/RESA and cross-reactive antigens in Plasmodium falciparum merozoite invasion in vitro.
Infect. Immun.
60:443-449[Abstract/Free Full Text].
|
| 39.
|
Wrighton, N.,
F. Farrell,
R. Chang,
A. Kashyap,
F. Barbone,
L. Mulcahy,
D. Johnson,
R. Barrett,
L. Jolliffe, and W. Dower.
1996.
Small peptides as potent mimetics of the protein hormone erythropoietin.
Science
273:458-464[Abstract].
|
| 40.
|
Zhong, G.,
G. Smith,
J. Berry, and R. Brunham.
1994.
Conformational mimicry of a chlamydial neutralization epitope on filamentous phage.
J. Biol. Chem.
269:24183-24188[Abstract/Free Full Text].
|
Infection and Immunity, September 1999, p. 4679-4688, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Casey, J. L., Coley, A. M., Street, G., Parisi, K., Devine, P. L., Foley, M.
(2006). Peptide mimotopes selected from a random Peptide library for diagnosis of epstein-barr virus infection.. J. Clin. Microbiol.
44: 764-771
[Abstract]
[Full Text]
-
Harris, K. S., Casey, J. L., Coley, A. M., Masciantonio, R., Sabo, J. K., Keizer, D. W., Lee, E. F., McMahon, A., Norton, R. S., Anders, R. F., Foley, M.
(2005). Binding Hot Spot for Invasion Inhibitory Molecules on Plasmodium falciparum Apical Membrane Antigen 1. Infect. Immun.
73: 6981-6989
[Abstract]
[Full Text]
-
Casey, J. L., Coley, A. M., Anders, R. F., Murphy, V. J., Humberstone, K. S., Thomas, A. W., Foley, M.
(2004). Antibodies to Malaria Peptide Mimics Inhibit Plasmodium falciparum Invasion of Erythrocytes. Infect. Immun.
72: 1126-1134
[Abstract]
[Full Text]
-
Coley, A. M., Campanale, N. V., Casey, J. L., Hodder, A. N., Crewther, P. E., Anders, R. F., Tilley, L. M., Foley, M.
(2001). Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides. Protein Eng Des Sel
14: 691-698
[Abstract]
[Full Text]
-
Jouault, T., Fradin, C., Dzierszinski, F., Borg-Von-Zepelin, M., Tomavo, S., Corman, R., Trinel, P.-A., Kerckaert, J.-P., Poulain, D.
(2001). Peptides that mimic Candida albicans-derived {beta}-1,2-linked mannosides. Glycobiology
11: 693-701
[Abstract]
[Full Text]